Sunday, October 24, 2010

GE Health to Buy Clarient in $580 Million Deal

*Look at the list of corrupt companies in this article! 

October 22, 2010, 8:34 AM

GE Healthcare said Friday that it had agreed to buy Clarient, a molecular diagnostics firm, which it says will help the company better diagnose and characterize cancer, in a deal worth about $580 million.

John Dineen, chief executive of GE Healthcare, said the acquisition “will accelerate our expansion into cancer diagnostics and therapy selection tools,” adding that he hoped to build a diagnostics business worth more than $1 billion.

Clarient hired Goldman Sachs as financial adviser and Latham & Watkins as counsel. GE Healthcare hired JP Morgan as adviser and Sidley Austin as counsel.

1 comment:

Anonymous said...

So Sidley Austin raises its ugly head again. Perhaps the Bhopal plant was not enough for them and more mayhem is required. Michelle Obama (nee Robinson) will need a job when her current position is undercut by the Foreigner in the Presidency. Of course cancer is likely a man made disease with Monsanto Genetically Modified seeds written all over it (Speculation on Monsanto and cancer ,there but with reason).